ACOG Addresses Thrombocytopenia in Pregnancy

Share this content:
ACOG Addresses Thrombocytopenia in Pregnancy
ACOG Addresses Thrombocytopenia in Pregnancy

WEDNESDAY, Aug. 24, 2016 (HealthDay News) -- Thrombocytopenia is common in pregnancy and can have causes that are serious medical disorders, with potential for maternal and fetal morbidity, according to a Practice Bulletin published in the September issue of Obstetrics & Gynecology.

Researchers from the American College of Obstetrics and Gynecology discuss thrombocytopenia in pregnancy, including definition and obstetric management.

The authors note that thrombocytopenia is frequently diagnosed by obstetricians in pregnant women as platelet counts are included as part of routine prenatal screening. Thrombocytopenia is defined as a platelet count of less than 150 × 109/L and is seen in 7 to 12 percent of pregnancies. Various physiologic or pathologic conditions can cause thrombocytopenia, including some that are unique to pregnancy, such as hypertension in pregnancy. Other causes include primary and secondary immune thrombocytopenia, association with systemic conditions, and congenital thrombocytopenia. Some causes are serious medical conditions, which could potentially cause maternal and fetal morbidity. Other conditions, such as gestational thrombocytopenia are benign, with no maternal or fetal risks. Controversies surround obstetric management of the condition due to the increased recognition of maternal and fetal thrombocytopenia.

"Clinicians must weigh the risks of maternal and fetal bleeding complications against the costs and morbidity of diagnostic tests and invasive interventions," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Gene Tx Approved for Certain Types of B-Cell Lymphoma

Gene Tx Approved for Certain Types of B-Cell ...

First such treatment for certain types of non-Hodgkin lymphoma

Uninsurance Down by One-Third for Cancer Diagnoses in 2014

Uninsurance Down by One-Third for Cancer Diagnoses in ...

Significant decreases in uninsurance seen across all stages and sites assessed in first year of ACA

Diabetes Ups Risk of MACE in Acute Coronary Syndromes

Diabetes Ups Risk of MACE in Acute Coronary ...

Diabetes, but not pre-diabetes, tied to increased risk of major adverse cardiac events in adjusted model

is free, fast, and customized just for you!

Already a member?

Sign In Now »